Smoking and fracture risk: a meta-analysis

By J. Kanis, O. Johnell, A. Odén, H. Johansson, C. Laet, John A. Eisman, S. Fujiwara, H. Kröger, Eugene V. McCloskey, D. Mellström and 5 more. Osteoporosis International, 2005

980 citations recorded by the source corpus.

Subfields: Oncology, Orthopedics and Sports Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/5a83ae5f4484b8286e940267e79893066bf1630a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. H. Johansson
2. J. Kanis
3. O. Johnell
4. Eugene V. McCloskey
5. A. Odén
6. J. Reginster
7. Chris Cooper
8. F. Borgström

In Orthopedics and Sports Medicine

1. J. Kanis
2. Chris Cooper
3. J. Reginster
4. Eugene V. McCloskey
5. H. Johansson
6. R. Rizzoli
7. on behalf of the International Osteoporosis Foundation
8. A. Odén

In Surgery

1. J. Kanis
2. Chris Cooper
3. Eugene V. McCloskey
4. J. Reginster
5. H. Johansson
6. R. Rizzoli
7. A. Odén
8. O. Johnell

Citations in the corpus

• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2018, background): “Doseresponses are also evident for glucocorticoid exposure [93], cigarette smoking [61] and alcohol intake [60].”
• FRAX™ and the assessment of fracture probability in men and women from the UK (2008, methodology): “Details of each of the cohorts have been recently published elsewhere [10–16].”
• The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (2007, neutral): “These comprised a parental history of hip fracture [11], exposure to systemic glucocorticoids [12], a prior history of fragility fracture [13], current smoking [ 18 ], high intake of alcohol (>2 units daily on average) [16] and the presence of rheumatoid arthritis [12].”
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, background): “Dose responses are also evident for glucocorticoid exposure [81], cigarette smoking [82] and alcohol intake [62].”
• Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK (2008, background): “for 3 months or more) of oral glucocorticoids [17], rheumatoid arthritis [17], current cigarette smoking [18] and high alcohol consumption (3 or more units/daily) [19].”
• An overview and management of osteoporosis. (2017, background): “Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, et al. Smoking and fracture risk: a meta-analysis.”
• FRAX and its applications to clinical practice. (2009, background): “By contrast, there is good evidence that the risk associated with excess alcohol consumption, cigarette smoking and the use of glucocorticoids is dose-responsive [18–20].”